TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “ Titan Medical Inc. ”) (“the “ Resulting Issuer ” or the “ Corporation ”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. (“ Conavi ”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the “ Transaction ”).... Read More

TORONTO, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that, in connection with its amalgamation agreement (“ Amalgamation Agreement ”) with Conavi Medical Inc. (“ Conavi ”) providing for the combination of the companies in an all-stock transaction (the “ Transaction ”), Conavi has closed its previously announced concurrent private placement of... Read More

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that following its annual general meeting held on September 30, 2024 (the “ Meeting ”) and in accordance with Titan’s Majority Voting Policy (the “ Voting Policy ”), Anthony Giovinazzo, Cathy Steiner, Cary Vance and Paul Cataford have tendered to the Board of Directors (the “ Board ”) their resignations as... Read More

TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announced the voting results from its Annual General and Special Meeting of Shareholders (the “ AGM ”) held virtually via live audio webcast on September 30, 2024. Shareholders voted in favour of all management resolutions proposed in Titan’s management information circular dated August 30, 2024 (the “ Circular ”).... Read More

TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that its board of directors (the “ Board ”) has approved the voluntary delisting (the “ Delisting ”) of Titan’s common shares (the “ Titan Shares ”) from the Toronto Stock Exchange (the “ TSX ”). Subject to approval by the TSX and the completion of all closing conditions for the Transaction (defined below) it... Read More

TORONTO, Ontario, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Conavi Medical Inc. (“ Conavi ”) has received the requisite shareholder approval required to proceed with the proposed combination of Titan and Conavi (the “ Amalgamation ”) in an all-stock transaction (the “ Transaction ”). This Transaction will constitute a reverse takeover of Titan. The... Read More

TORONTO, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) released a reminder for shareholders to vote ahead of Titan’s annual and special shareholders meeting (the “ Meeting ”) scheduled to be held on Monday, September 30, 2024. Less than half of the Titan common shares have been voted in advance of the Meeting. VOTE TODAY. The Management Information Circular (the “ Circular... Read More

TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc . (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that Conavi Medical Inc. (“ Conavi ”) will be joining the previously announced Titan Q&A session to be held on Thursday, September 19, 2024 at 5:00 pm ET in connection with the proposed business combination between Titan and Conavi to be considered at the annual general meeting of Titan on September 30, 2024.... Read More

TORONTO, Ontario, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that Titan management will host a webcast Q&A session on Thursday, September 19, 2024 at 5:00 pm ET in connection with filing and mailing of the management information circular, which was announced by press release issued on September 6, 2024. Titan will provide prepared remarks followed by a Q&A session. Paul... Read More

TORONTO, Ontario, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce the filing and mailing of its management information circular (the “ Circular ”) with respect to the amalgamation agreement (“ Amalgamation Agreement ”) with Conavi Medical Inc. (“ Conavi ”) providing for the combination of the companies in an all-stock transaction (the “ Transaction ”). This... Read More

TORONTO, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ” or the “ Company ”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three and six months ended June 30, 2024. Recent Activities in Q2 2024: On May 29, 2024, the Company announced an amendment to the timeframe under which certain closing conditions must be met in the amalgamation agreement dated March 17, 2024 with Conavi... Read More

TORONTO, Ontario, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into a third amending agreement dated August 13, 2024 (the “ Amending Agreement No. 3 ”), in respect of the previously announced amalgamation agreement dated March 17, 2024, as previously amended on May 28, 2024 and on July 5, 2024 (collectively, the “ Amalgamation Agreement ”)... Read More

TORONTO, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that it has entered into a second amending agreement dated July 5, 2024 (the “ Amending Agreement ”), in respect of the previously announced amalgamation agreement dated March 17, 2024, as initially amended by an amending agreement on May 28, 2024 (collectively the “ Amalgamation Agreement ”) among Conavi... Read More

TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “ Amending Agreement ”), in respect of the previously announced amalgamation agreement dated March 17, 2024 (the “ Amalgamation Agreement ”) among Conavi Medical Inc. (“ Conavi ”), 1000824255 Ontario Inc. (a wholly-owned... Read More

TORONTO, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is providing an update on its planned merger with Conavi Medical Inc. (“ Conavi ”) pursuant to the definitive amalgamation agreement (the “ Amalgamation Agreement ”) dated March 17, 2024 (the “ Transaction ”), as previously announced on March 18, 2024 and April 22, 2024. Titan and Conavi are both working on satisfying the... Read More

TORONTO, Ontario, May 13, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ” or the “ Company ”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three months ended March 31, 2024. Recent Activities: On March 18, 2024, the Company announced it has entered into a definitive amalgamation agreement (the “ Definitive Agreement ”) with Conavi Medical Inc. (“ Conavi ”) to combine the companies in an all-stock... Read More

TORONTO, Ontario, April 22, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to provide this update on its planned merger with Conavi Medical Inc. (“ Conavi ”) as previously announced on March 18, 2024 (the “ Transaction ”). As previously announced, Titan has entered into a definitive amalgamation agreement (the “ Amalgamation Agreement ”) dated March 17, 2024 with Conavi Medical Inc.... Read More

TORONTO, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that it has entered into a settlement agreement with a contract manufacturer (“ Contractor ”). Titan has reached a settlement agreement in connection with a dispute with the Contractor. Under the terms of the settlement, Titan has agreed to pay the Contractor an aggregate of US$2 million, with the final... Read More

TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ” or the “ Company ”) (TSX: TMD; OTC: TMDIF), today reported financial results for the fiscal year ended December 31, 2023. Recent Activities: On August 14, 2023, the Company announced the appointment of Dr. Daniel O’Brien, MD, MBA, Ph.D to its Board of Directors. On August 21, 2023, the Company announced a licensing agreement with Auris Health,... Read More

TORONTO, Ontario, March 20, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that management will host a webcast Q&A session on March 27, 2024 at 1:00 p.m. ET in connection with the merger agreement entered into by Titan with Conavi Medical Inc. (“ Conavi ”), which was announced by press release issued on March 18, 2024. Titan will provide prepared remarks followed by a Q&A session.... Read More

TORONTO, Ontario, March 18, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into a definitive amalgamation agreement (the “ Amalgamation Agreement ”) dated March 17, 2024 with Conavi Medical Inc. (“ Conavi ”) to combine the companies in an all-stock transaction. The combined company will focus on continuing to commercialize Conavi’s Novasight Hybrid™... Read More

TORONTO, Ontario, March 04, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ” or the “ Company ”) (TSX: TMD; OTC: TMDIF), announced today that the Company plans to issue its year-end 2023 financial results after the market closing on March 29, 2024. About Titan Medical Titan Medical Inc. (TSX: TMD; OTC: TMDIF), a medical technology company headquartered in Toronto, Ontario, has developed an expansive patent portfolio... Read More

TORONTO, Ontario, May 15, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ” or the “ Company ”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Order s (“ NP 12-203 ”). On March 22, 2023, and as further updated on April 3, 2023, April 17, 2023, and May 1, 2023, the Company announced (the “... Read More

TORONTO, Ontario, May 01, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Order s (“NP 12-203”). On March 22, 2023, and as further updated on April 3, 2023 and April 17, 2023, the Company announced (the “ Default Announcement ”)... Read More

TORONTO, Ontario, April 17, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“ NP 12-203 ”). On March 22, 2023, and as further updated on April 3, 2023, the Company announced (the “ Default Announcement ”) that under NP... Read More

TORONTO, ON, April 04, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) announces that it has been granted a management cease trade order (“MCTO”) by the Ontario Securities Commission (the “OSC”), as its principal regulator, under National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). On March 22, 2023, the Company announced that (i) it would... Read More

TORONTO, ON, April 03, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today provided an update on its annual filings and certain other corporate and operational matters. On March 22, 2023, the Company announced that it would not be filing its annual financial statements, the related management’s discussion and analysis and annual information form, and the accompanying chief... Read More

TORONTO, ON, March 22, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today announces that, as a result of certain financial and operational challenges that the Company has experienced over the past several months and as a result of the Company devoting significant management resources to rectifying these challenges, the Company will not be filing its annual financial... Read More

TORONTO, ON, March 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced that it has received a decision of the Nasdaq Hearings Panel (the “Panel”) advising the Company that effective at the open of business on March 10, 2023, the Company’s common shares will be delisted from The Nasdaq Stock Market (“Nasdaq”). On December 30, 2021, Nasdaq Listing Qualifications... Read More

Toronto, Ontario, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced senior leadership changes and the receipt of a notification from the Nasdaq Stock Market LLC Listing Qualifications Department stating that following the resignation of Heather Knight from the Company’s board of directors and audit committee, the Company no longer complies with Nasdaq’s... Read More

TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today provided an update on the previously announced review and evaluation of strategic alternatives. As previously disclosed on November 30, 2022, Titan’s Board of Directors determined that it was in the best interests of the Company and its stakeholders to undertake a review and evaluation of strategic... Read More

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the unveiling of its next generation technology and participation in meetings to support the strategic review process announced on November 30, 2022 alongside the... Read More

TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that, on December 27, 2022, the Nasdaq Listing Qualifications Staff (the “Staff”) notified the Company that, based upon the Company’s... Read More

TORONTO, ON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that the United States Patent and Trademark Office (USPTO) recently issued patent No. 11,504,191, titled “Graphical User Interface for a Robotic Surgical... Read More

TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that in view of the commencement of the strategic review process announced on November 30, 2022, the special meeting of its shareholders scheduled for January 12, 2023 will be suspended and, if appropriate and necessary, rescheduled to a... Read More

TORONTO, ON, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will implement certain cost-cutting measures with a view to preserving capital to support the strategic review process announced on November 30, 2022 while allowing the company to continue working on the... Read More

TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (“Titan” or the “Company”), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that its Board of Directors (or the “Board”), in consultation with its financial and legal advisors, has determined that it is in the best interest of the Company and its stakeholders to undertake a review and... Read More

TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced its attendance at the American Association of Gynecologic Laparoscopy (AAGL) 51 st Global Congress on minimally invasive gynecologic surgery (MIGS) being held December 1-4, 2022 in Aurora, Colorado. “Participation at the American... Read More

TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and nine months ended September 30, 2022. Additionally, the company announced that a special meeting of shareholders will be held... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its third quarter 2022 financial results prior to market opening on Thursday, November 10, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business developments in the period.... Read More

Titan Medical Inc. (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that Eric Heinz has been appointed as the company’s Vice President, Market and Corporate Development. Mr. Heinz will be responsible for developing and executing on strategic business plans to expand and... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the publication of international patent application No. PCT/CA2022/050392, which the company anticipates pursuing in the United States and other key markets under the Patent Cooperation Treaty (PCT). The... Read More

Titan Medical Inc . (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the signing of a Definitive Agreement with Medtronic plc (“Medtronic”) (NYSE: MDT), a global leader in healthcare technology. The Definitive Agreement comprises a limited development program, building on... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will present an overview of its Enos™ robotic single access surgical system at the H.C. Wainwright Global Investment Hybrid Conference, taking place September 12-14, 2022 at the Lotte New York Palace Hotel in New York, NY, and virtually. Cary Vance, Titan’s... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and six months ended June 30, 2022. “I am thrilled to lead Titan Medical as President and CEO and have been committed to the company’s mission to improve surgical outcomes as... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its second quarter 2022 financial results prior to market opening on Thursday, August 11, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business developments in the period.... Read More

Titan Medical Inc. (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that Cary G. Vance has been appointed as the company’s President and CEO effective July 1, 2022. Mr. Vance will succeed Paul Cataford, Titan’s chair of the board of directors, who has served as Interim... Read More

Titan Medical Inc. (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") has notified the company that it has been granted an additional 180 calendar day period, through December 26, 2022, to... Read More

Titan Medical Inc. (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that multiple disruptions have resulted in an updated Investigational Device Exemption (IDE) submission timeline for the Enos™ robotic single access surgery system. The company now expects the IDE... Read More

Titan Medical Inc. (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced its participation at this year’s Society of Robotic Surgery (SRS) Annual Meeting. On Thursday, June 30, 2022 Chris Seibert, Titan’s Vice President of Upstream Marketing, will participate on a panel... Read More

Titan Medical Inc . (Nasdaq : TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has signed an agreement with Nissha Medical Technologies for the manufacture of surgical consumables. These single-use surgical components will be used for verification and validation testing, and... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the voting results form the company’s Annual and Special Meeting of its shareholders held on Wednesday June 8, 2022. All of management’s nominees for election were duly elected as directors of the company by... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the appointment of Bill Fahey as Vice President, Manufacturing and Operations. In this new role, Mr. Fahey will be a key member of the senior leadership team and be responsible for both in-house and contract... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced, after careful consideration and a review of the company’s future needs, that Perry Genova, Senior Vice President of Research and Product Development, will depart the company effective immediately. “As we... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022. “The entire team is focused on driving performance and progress supporting our IDE application submission milestone. We are also starting to... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that its 2022 Annual and Special Meeting (“the Meeting”) is scheduled for Wednesday, June 8, 2022 at 4:00 p.m. ET to be held virtually at https://web.lumiagm.com/432237190 . As described in the distributed... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced receipt of a $2.6 million purchase order from Medtronic plc (NYSE: MDT), a global leader in healthcare technology. The order covers the purchase of instruments and cameras that will be used in preclinical... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its first quarter 2022 financial results prior to market opening on Thursday, May 12, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include Paul... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will present an overview of its Enos™ robotic single access surgical system at the Bloom Burton & Co. Healthcare Investor Conference, taking place May 2-3, 2022 at the Metro Toronto Convention Center. Paul Cataford, Titan’s interim President and CEO, will... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and twelve months ended December 31, 2021. Key Accomplishments and Recent Activities Received payment and retired senior secured loan from Medtronic after completion of final... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its year end 2021 financial results prior to market opening on Thursday, March 24, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include Paul... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced the company will present an overview of its Enos™ robotic single access surgical system at Oppenheimer’s 32 nd Annual Healthcare Conference, a virtual investor conference taking place March 15-17, 2022. Paul Cataford, Titan’s interim President and CEO, will provide a company... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has surpassed 200 patents and patent applications. This important milestone demonstrates the company’s commitment to being an innovation leader in single access robotic-assisted surgery. This broad... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the design and development of innovative surgical technologies for robotic single access surgery, announced today that it has received payment from Medtronic plc after successfully achieving the final milestone under the development and license agreement announced on January 4, 2022. In addition, the senior secured loan from Medtronic has... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the design and development of innovative surgical technologies for robotic single access surgery, announced today that it has signed a manufacturing and supply agreement with Benchmark Electronics, Inc. (NYSE: BHE) to produce Titan’s innovative Enos™ robotic single access surgical system workstations and patient carts. These Benchmark... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of innovative single access robotic-assisted surgery systems and technology, announced today it is scheduled to participate at the H.C. Wainwright & Company BioConnect 2022 Conference, a virtual investor conference taking place January 10-13, 2022. Paul Cataford, Titan’s interim President and CEO, will... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of innovative single access robotic-assisted surgery systems and technology, announced today that it completed, on schedule, the final milestone under the development and license agreement with Medtronic plc (NYSE: MDT), the world’s leading medical technology company. With the successful completion of... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of an innovative single access robotic-assisted surgery system, today received notification from the Nasdaq Stock Market LLC Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of an innovative single access robotic-assisted surgery system, announced that President and Chief Executive Officer David McNally has stepped down as President and CEO, and resigned from the Board of Directors effective today. Paul Cataford, Chair of the Board, has been appointed Interim President and... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-assisted surgery that requires a single patient access point, today announced financial results for the three and nine months ended September 30, 2021. During the third quarter of 2021 and in recent weeks, Titan made significant advancements including... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced changes to its Surgeon Advisory Board (SAB) comprised of industry leaders in single access and robotic-assisted surgery. The SAB will work cohesively with management to advance the company’s Enos™ robotic single access... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery today announced that the company plans to issue its third quarter 2021 financial results prior to market opening on Thursday, November 11, 2021. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss... Read More

Encode Ideas, L.P. Initiates Research on Titan Medical, Inc. (NASDAQ: TMDI) (TSX: TMD). The full research publication is available here and available on our website at www.encodelp.com . A summary follows: Encode Ideas, L.P. is initiating coverage on Titan Medical, Inc. as a High Conviction Investment Idea. Titan is a medical device company headquartered in Toronto, Ontario with R&D facilities in Chapel Hill, North Carolina,... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations. GLP is a set of principles intended to assure the... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system and participate in one-on-one investor meetings at two upcoming... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system at the H.C. Wainwright 23rd Annual Global Investment Conference on... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced financial results for the three and six months ended June 30, 2021. During the second quarter of 2021, the company made solid progress under the development and license agreement with Medtronic plc, strengthened its... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that the company plans to issue its second quarter 2021 financial results prior to market opening on Wednesday, August 11, 2021. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and... Read More

Titan Medical Inc. ( Nasdaq : TMDI; TSX: TMD ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs. “We are delighted that Tammy has joined Titan Medical’s leadership team as we advance our Enos™ robotic single access surgery system toward human clinical... Read More

Titan Medical Inc. (Nasdaq:TMDI; TSX:TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, and Stephen Lemieux, Chief Financial Officer, will be meeting with investors during the Alliance Global Partners Virtual MedTech Summer Investor Conference on Thursday, July 29, 2021. About... Read More

Titan Medical Inc. ( Nasdaq:TMDI; TSX:TMD ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Stephen Lemieux as the Chief Financial Officer of the Company. Mr. Lemieux has more than 18 years of experience working in Nasdaq and TSX listed companies primarily focused in the health care industry. Mr. Lemieux has been... Read More

Titan Medical Inc. ( Nasdaq : TMDI; TSX: TMD ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the voting results from the company’s Annual and Special Meeting of its Shareholders held on Wednesday, June 9, 2021. All of management’s nominees for election were duly elected as directors of the company by the shareholders presented or... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the second technical milestone under the development and license agreement with Medtronic plc (NYSE: MDT), and received a U.S. $10 million payment for licensing the developed technologies to Medtronic. The development and... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system at the Oppenheimer MedTech Summit Investor Conference on Wednesday, May 26, 2021 available at... Read More

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company plans to issue its first quarter financial results prior to market opening Monday, May 17, 2021 and management will host an investor audio webcast at 4:30 p.m. ET to discuss financial results and... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Kristen Galfetti, MBA, as its Vice President, Investor Relations & Corporate Communications and Chien Huang as Vice President Finance. Ms. Galfetti will be located in Boston and Mr. Huang... Read More

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that David McNally, President, CEO and Chairman of Titan Medical, will present an overview of the Company and its Enos™ robotic single access surgical system at the Bloom Burton & Co. Healthcare Investor Conference... Read More

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that, David McNally, President, CEO and Chairman and Monique Delorme, CFO of Titan Medical, will participate in two upcoming virtual investor conferences. On March 16, 2021, Titan Medical will lead a day of... Read More

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced a corporate update in conjunction with its presentation at the H.C. Wainwright Global Life Sciences Conference. David McNally, President, CEO and Chairman of Titan Medical, will provide an overview of the Company and... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it closed its previously announced offering of 8,335,000 units of the Company (“ Units ”) sold on a “bought deal” basis for gross proceeds of US $20,004,000 (the “ Offering ”). Bloom Burton Securities... Read More

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the release of its annual financial results for the years ended December 31, 2020 and 2019. During the year ended December 31, 2020, the Company generated revenue of $20.0 million, resulting from development and... Read More

Tit an Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed and been receipted for a final short form prospectus with applicable securities regulators in Ontario, British Columbia and Alberta in connection with its previously announced offering of... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the launch of “Titan Living Labs”, a new media-rich addition to its website providing access to the stories behind the design, engineering and innovative technologies employed by Titan’s engineering team... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company plans to issue its fourth quarter and year-end financial results prior to market opening Monday, February 22, 2021 and management will host an investor audio webcast at 4:30 pm ET to discuss... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed a preliminary short form prospectus with applicable securities regulators in Ontario, British Columbia and Alberta in connection with its previously announced offering of 8,335,000 units... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc. (the “ Underwriter ”) to increase the amount of its previously announced “bought deal” offering. The Underwriter has now agreed to purchase, on a... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc. (the “ Underwriter ”) pursuant to which the Underwriter has agreed to purchase, on a “bought deal” basis, 6,250,000 units of the Company (the “ Units... Read More

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX : TMD ) ( Nasdaq : TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it closed its previously announced offering of 6,451,613 units of the Company (“ Units ”) sold on a “bought deal” basis for gross proceeds of approximately US $10,000,000.00 (the “ Offering ”). Bloom... Read More